BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 44462)

  • 1. [Therapy of extrapyramidal motor disturbances by tiaprid (author's transl)].
    Claus D; Aschoff JC
    Arch Psychiatr Nervenkr (1970); 1979; 227(2):151-8. PubMed ID: 44462
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment of tardive dyskinesia.
    Deleu D
    Am J Psychiatry; 1988 Sep; 145(9):1182-3. PubMed ID: 2901238
    [No Abstract]   [Full Text] [Related]  

  • 3. [Influence of clozapine on neuroleptigenic extrapyramidal motor disturbances (author's transl)].
    Zander KJ; RĂ¼ther E
    Arzneimittelforschung; 1978; 28(9):1495-6. PubMed ID: 38808
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Dyskinetic syndromes in psychiatric patients (author's transl)].
    Lutrand JC; Ducamin JP
    Sem Hop; 1978 Dec 18-25; 54(45-46):1465-8. PubMed ID: 34882
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Therapeutical approach to involuntary movements (author's transl)].
    Allain H; Sabouraud O
    Sem Hop; 1979 Feb 8-15; 55(5-6):262-4. PubMed ID: 219537
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Treatment of abnormal movements of extrapyramidal origin with tiapride].
    Ferrari G; Lovaste MG; Girardi P; Boninsegna C
    Riv Neurol; 1981; 51(3):125-33. PubMed ID: 7256107
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of permanent tardive dyskinesia with tiapride, a selective D2-receptor blocking agent.
    Leblhuber F
    Clin Neuropharmacol; 1987 Oct; 10(5):458-61. PubMed ID: 2902921
    [No Abstract]   [Full Text] [Related]  

  • 8. [A clinical trial of tiapride in neurology (author's transl)].
    Lipcsey A; Nagy E
    Sem Hop; 1982 Apr; 58(14):867-71. PubMed ID: 6281900
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tiapride in the treatment of tardive dyskinesia.
    Buruma OJ; Roos RA; Bruyn GW; Kemp B; van der Velde EA
    Acta Neurol Scand; 1982 Jan; 65(1):38-44. PubMed ID: 6121443
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Indications for the use of tiapride in extrapyramidal pathology].
    Petit H
    Lille Med; 1979 Apr; 24(4):339-44. PubMed ID: 39203
    [No Abstract]   [Full Text] [Related]  

  • 11. [Abnormal movements and shaking in geriatrics (author's transl)].
    Chabaud R; Guenoun M; Taddei JP; Guillou J
    Sem Hop; 1979 Mar 8-15; 55(9-10):465-9. PubMed ID: 38513
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Extrapyramidal effects of benzamides.
    Chouza C; Caamano JL; Romero S; Lorenzo J; Feres S
    Adv Biochem Psychopharmacol; 1985; 40():43-6. PubMed ID: 4025040
    [No Abstract]   [Full Text] [Related]  

  • 13. [The possibility of pharmacologic therapy of extrapyramidal hyperkineses with tiapride].
    Grass H; Gottschaldt M
    Psychiatr Neurol Med Psychol (Leipz); 1983 Apr; 35(4):222-9. PubMed ID: 6223330
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Therapeutical study in patients admitted to an emergency unit (author's transl)].
    Favarel-Garrigues JC
    Sem Hop; 1979 Mar 18-25; 55(1112):592-5. PubMed ID: 38506
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Atypical neuroleptics: clozapine and the benzamides in the prevention and treatment of tardive dyskinesia.
    Pi EH; Simpson GM
    Mod Probl Pharmacopsychiatry; 1983; 21():80-6. PubMed ID: 6140635
    [No Abstract]   [Full Text] [Related]  

  • 16. [Spontaneous oral dyskinesia. Successful treatment with tetrabenazine (author's transl)].
    Schumm F; Dichgans J; Zeller E
    Arch Psychiatr Nervenkr (1970); 1981; 230(4):315-23. PubMed ID: 7316728
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of anticholinergic drugs in extra-pyramidal syndromes.
    Hunter KR
    Neuropharmacology; 1981 Dec; 20(12B):1315-7. PubMed ID: 6119641
    [No Abstract]   [Full Text] [Related]  

  • 18. The substituted benzamides--a novel class of dopamine antagonists.
    Jenner P; Marsden CD
    Life Sci; 1979 Aug; 25(6):479-85. PubMed ID: 40086
    [No Abstract]   [Full Text] [Related]  

  • 19. Assessment of the therapeutic range of tiapride in patients with tardive dyskinesia.
    Roos RA; Van der Velde EA; Buruma OJ; de Wolff FA
    J Neurol Neurosurg Psychiatry; 1986 Sep; 49(9):1055-8. PubMed ID: 3760895
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Tiapride therapy of centrally produced dyskinesia. Examination of the serum levels of protein, LH and FSH (author's transl)].
    Aschoff JC; Claus D; Hetzel WD
    Arzneimittelforschung; 1982; 32(3):286-9. PubMed ID: 6805485
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.